DrugAug 3, 2022
Lansoprazole Delayed-Release Orally Disintegrating Tablets, 35 mg, 100-count blisters per recall — FDA D-1288-2022
FAILED DISSOLUTION SPECIFICATIONS
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
August 2022 recalls — page 13
These records include useful source details for the selected month.
DrugAug 3, 2022
Mylan Pharmaceuticals Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL recall — FDA D-1292-2022
Labeling: Missing label: Label missing from some prefilled pens.
Class IFDA: TerminatedMylan Pharmaceuticals Inc.
DrugAug 3, 2022
Testosterone Gel 1% recall — FDA D-1289-2022
Superpotent Drug: Out of specification assay result was obtained during stability testing.
Class IIFDA: TerminatedTeva Pharmaceuticals USA Inc.
DrugAug 3, 2022
The Procter & Gamble Company Crest 3D White Fluoride Anticavity Toothpaste, Advanced Triple recall — FDA D-1290-2022
Labeling: Missing label: the product tube was missing a label and contained a different formulation.
Class IIIFDA: CompletedThe Procter & Gamble Company
DrugAug 3, 2022
Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100-count blisters per recall — FDA D-1287-2022
FAILED DISSOLUTION SPECIFICATIONS
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
How to use this monthly recall archive
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.